Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M304104200 on May 22, 2003

J. Biol. Chem., Vol. 278, Issue 34, 32107-32114, August 22, 2003
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/34/32107    most recent
M304104200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lamb, H. K.
Right arrow Articles by Hawkins, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lamb, H. K.
Right arrow Articles by Hawkins, A. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Negative Transcriptional Regulator NmrA Discriminates between Oxidized and Reduced Dinucleotides*

Heather K. Lamb {ddagger} §, Kris Leslie § ¶, Anna L. Dodds {ddagger}, Margaret Nutley ||, Alan Cooper ||, Christopher Johnson {ddagger}, Paul Thompson {ddagger}, David K. Stammers ¶ ** and Alastair R. Hawkins {ddagger} {ddagger}{ddagger}

From the {ddagger}School of Cell and Molecular Biosciences, Catherine Cookson Building, University of Newcastle upon Tyne, Framlington Place, NE2 4HH, United Kingdom, Division of Structural Biology, The Henry Wellcome Building for Genomic Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, United Kingdom, and the ||Department of Chemistry, University of Glasgow, Glasgow G12 8QQ, Scotland, United Kingdom

Received for publication, April 18, 2003 , and in revised form, May 14, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
NmrA, a transcription repressor involved in the regulation of nitrogen metabolism in Aspergillus nidulans,is a member of the short-chain dehydrogenase reductase superfamily. Isothermal titration calorimetry and differential scanning calorimetry have been used to show NmrA binds NAD+ and NADP+ with similar affinity (average KD 65 µM) but has a greatly reduced affinity for NADH and NADPH (average KD 6.0 mM). The structure of NmrA in a complex with NADP+ reveals how repositioning a His-37 side chain allows the different conformations of NAD+ and NADP+ to be accommodated. Modeling NAD(P)H into NmrA indicated that steric clashes, attenuation of electrostatic interactions, and loss of aromatic ring stacking can explain the differing affinities of NAD(P)+/NAD(P)H. The ability of NmrA to discriminate between the oxidized and reduced forms of the dinucleotides may be linked to a possible role in redox sensing. Isothermal titration calorimetry demonstrated that NmrA and a C-terminal fragment of the GATA transcription factor AreA interacted with a 1:1 stoichiometry and an apparent KD of 0.26 µM. NmrA was unable to bind the nitrogen metabolite repression signaling molecules ammonium or glutamine.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Neurospora crassa, Aspergillus nidulans, and other ascomycetous fungi are able to utilize a wide array of nitrogen sources, and many of the pathways involved are regulated at the level of transcription by pathway-specific control proteins. When the preferred nitrogen sources ammonium or glutamine are present in the growth medium with an alternative nitrogen source, the pathway for the non-preferred source remains inactive. This situation is known as nitrogen metabolite repression, and the alternate nitrogen utilization pathway is said to be repressed (1). These observations show there is a signal transduction pathway that responds to the presence of ammonium/glutamine and targets the control of transcription of the genes involved in nitrogen metabolism.

Two major classes of mutant affecting nitrogen metabolite repression have been isolated. The first class exemplified by the nmr-1 and nmrA genes of N. crassa and A. nidulans, respectively, has a partially de-repressed phenotype (2, 3) implying they act as negative transcription regulators.

The structures of the native form of the nmrA-encoded NmrA protein as well as a complex with NAD+ have been reported (4, 5). Structural comparisons reveal that NmrA shows an unexpected similarity to the short-chain dehydrogenase reductase (SDR) superfamily (5), with the closest relationship to UDP-galactose 4-epimerase (root mean square deviation for 251 equivalent {alpha}-carbons of 2.7 Å). Whereas UDP-galactose 4-epimerase has the conserved Tyr-X-X-X-Lys SDR catalytic motif (6, 7), in NmrA this is changed to Met-X-X-X-Lys. The loss of a key catalytic tyrosine implies NmrA is unlikely to be an active dehydrogenase. The N-terminal domain of NmrA consists of a Rossmann fold, which, despite lacking the characteristic nucleotide-binding motif Gly-X-X-Gly-X-X-Gly, is able to bind NAD+ (5). Prior to the structural work on NmrA, NAD+ binding was an unreported property of the protein that could not be predicted from bioinformatics or genetic studies. However, in order to assess the possible physiological significance of such binding, it is necessary to characterize the relative strength of NAD+ as well as NADP+ binding to NmrA in both their oxidized and reduced forms.

The nit-2 and areA genes that encode the GATA-binding NIT2 and AreA proteins of N. crassa and A. nidulans, respectively, exemplify the second class of mutants. These proteins contain single zinc fingers and are required to stimulate transcription of genes controlled by nitrogen metabolite repression (812). Loss of function mutants are unable to use non-preferred nitrogen sources and are said to have a repressed phenotype in contrast to the wild-type repressible phenotype.

The molecular mechanism of the signal transduction pathway responsible for nitrogen metabolite repression is complex and in A. nidulans includes control of mRNA stability mediated through the 3'-untranslated region of the areA mRNA and AreA-dependent re-modeling of chromatin domains (13, 14). In vivo post-translational modulation of NIT2 activity has been implicated, as in vitro the nmr1-encoded N-terminally deleted forms of NMR1 protein bind directly to the zinc finger region and the extreme C-terminal 30 amino acids of NIT2 (1517). The interactions were demonstrated in a qualitative manner by using the yeast two-hybrid system, as well as steady state techniques that included electrophoretic mobility shift assay and column binding using His6- and glutathione S-transferasetagged fragments of the NIT2 protein as a bait. No kinetic data nor the strength of the interaction with the wild-type NMR1 have been reported. Here we investigate the ligand binding properties of NmrA and show that it binds to a C-terminal fragment of AreA, the dinucleotides NAD+ and NADP+, but not their reduced forms, and not to the nitrogen metabolite signal molecules ammonium and glutamine. These properties of NmrA suggest a possible link to a redox-sensitive signal transduction pathway.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Materials—Chemicals and solvents were purchased from local suppliers and were of AnalaR or greater purity. Enzyme substrates were purchased from Sigma, and molecular biology reagents (which were used in accordance with the manufacturers recommendations) were purchased from Invitrogen, Amersham Biosciences, BCL, or the University of Newcastle upon Tyne Facility for Molecular Biology.

Molecular Biology and Biochemistry—Routine molecular biology protocols followed individual manufacturer's recommendations or were as described previously (18, 19). All DNA sequencing was carried out on double-stranded plasmid DNA using an ABI PRISM 377 DNA sequencer in the University of Newcastle upon Tyne Facility for Molecular Biology.

Construction of a Recombinant Plasmid for Expression in Escherichia coli—The areA deletion mutant areA662 was amplified by the PCR using 5' sense oligonucleotides (containing an NcoI recognition site) of sequence CCAGTCCAGGCGCCATGGAGAACGGAGAGC and a 3' antisense oligonucleotide (containing a HindIII site) of sequence CTTTAGAAGCTTACAAACTCA. The PCR used the following conditions: cycle 1–94 °C for 2 min, 50 °C for 2 min, 72 °C for 4 min; cycles 2–30 at 94 °C for 1 min, 50 °C for 2 min, and 72 °C for 4 min using "Expand" high fidelity Taq polymerase (Roche Applied Science). After suitable digestion, the DNA sequence was subcloned into the E. coli expression vector pRSETB (Invitrogen) placing it under the control of the isopropyl-1-thio-{beta}-D-galactopyranoside-inducible T7 promoter. This plasmid was designated pRF48.

Overproduction and Purification of the AreA662 Protein—500-ml cultures of E. coli strain BL21DE3 pLysS containing plasmids pRF48 were grown to an attenuation (D500) of 0.2 in rich medium at 37 °C in the presence of 50 µg of ampicillin ml1 and 35 µg ml1 chloramphenicol when 0.2 mg of isopropyl-1-thio-{beta}-D-galactopyranoside ml1 was added, and growth was continued for a further 4 h. After harvesting by centrifugation, the cell pellets were resuspended in 40 ml of 50 mM potassium phosphate, pH 7.2, 0.5 M NaCl, 1 mM DTT,1 1 mM benzamidine (buffer 1), and following sonication a cell-free extract was prepared by centrifugation at 2,500 x g for 30 min at 4 °C. Proteins in the sonicate capable of zinc binding were adsorbed onto a 27.15-ml chelating Sepharose column that had been charged to one-third capacity with zinc and equilibrated in buffer 1. Loosely bound proteins were eluted from the column with a 100-ml step wash of buffer 1 containing 2.0 M glycine. Tightly bound proteins were then eluted with a 50 mM potassium phosphate linear 6.0 to 4.0 pH gradient containing 0.5 M NaCl and 1 mM DTT, and AreA-containing fractions were identified by SDS-PAGE and pooled. The pooled fractions were dialyzed overnight at 4 °C against 5 liters of buffer containing 50 mM potassium phosphate, 0.5 M KCl, 1 mM DTT, 10 µM ZnSO4, pH 7.2, and subsequently concentrated 2–5-fold by pressure concentration using argon and a ChemLab concentrator in conjunction with a YM10 DIAFLO ultrafiltration membrane.

Purification of NmrA—NmrA was purified using the protocol described previously (4).

Circular Dichroism and Fluorescence Spectroscopy—The secondary structure of NmrA was probed by far-UV CD and the tertiary structure by near-UV CD spectroscopy. CD spectra were recorded from five accumulative scans at 20 °C using a Jobin-Yvon CD6 spectrometer (Longjumeau, France). Samples of NmrA in 50 mM KPO4, pH 7.4, were used at concentrations between 0.57 and 0.78 mg ml1. Each spectrum was corrected by subtraction of a comparative blank, and the readings were repeated in the presence of 2.0 mM ammonium chloride or glutamine.

Fluorescence emission spectra were recorded at 20 °C in an SLM 8100 spectrofluorometer operating in ratio mode with bandwidths of 8 mm for excitation (280 and 295 nm) and emission (range 295–430 nm); 5-mm pathlength quartz cuvettes (Hellma) were used containing 500 µl of sample in 50 mM KPO4, pH 7.4. Samples of NmrA in 50 mM KPO4,pH 7.4, were used at concentrations between 41 and 46 µg ml1, and the readings were repeated in the presence of 2.0 mM ammonium chloride or glutamine.

Isothermal Titration Calorimetry—Isothermal titration calorimetry experiments at 25 °C were performed using a high precision VP-ITC system (Microcal Inc.). For potential small effector molecule binding studies, NmrA in the calorimetric cell (1.4 ml) in the range 80–163 µM was titrated with either ammonium chloride, L-glutamine, NAD+, NADH, NADP+, or NADPH dissolved in the same buffer (50 mM potassium phosphate, 1 mM DTT, pH 7.2) at 1.5–4 mM initial concentrations in the injection syringe. Experiments designed to detect any heat of ionization associated with the buffer and NAD+, NADH, NADP+, or NADPH used 50 mM PIPES, HEPES, TES, or Tris buffers, 1.0 mM DTT, pH 7.2. For the study of protein-protein interactions, AreA662 in the calorimetric cell (1.4 ml) at concentrations in the range 37.5–50 µM were titrated with NmrA at a concentration of 454 µM in the injection syringe. The heat evolved following each 10-µl injection was obtained from the integral of the calorimetric signal. The heat due to the binding reaction was obtained as the difference between the heat of reaction and the corresponding heat of dilution. Analysis of data was performed using Microcal Origin Software. AreA662 is encoded by a fragment of the areA gene subcloned into the E. coli expression vector pRSETB and has a heterologous N-terminal additional sequence that contains 6 histidine residues facilitating purification by immobilized metal affinity chromatography (see above). As a control we purified the protein encoded by the plasmid pRF12 (20) by using the same method as AreA662 because it has the same N-terminal heterologous extension. When this protein was used in the ITC cell at a concentration of 35 µM, no heat exchange above base-line values was observed when NmrA was titrated into the protein solution. This control demonstrates that the heat exchange seen when NmrA is titrated into AreA662 in the ITC cell was due to a specific interaction between NmrA and AreA662.

Differential Scanning Calorimetry—Differential scanning calorimetry measurements on NmrA were made using Microcal VP-DSC or MCS instruments at a scan rate of 1 °C per min and a protein concentration of 17.3 (VP-DSC) or 108 µM (MCS). Protein was dialyzed in 50 mM KPO4, pH 6.6, 1 mM DTT, and the dialysis buffer was retained to dissolve ligands, to dilute proteins, and for base-line controls. DSC experiments were repeated with addition of 3 mM putative effector (NAD+, NADH, NADP+, and NADPH) under otherwise identical conditions. Deconvolution analysis was performed using the non-two-state model using the Microcal Origin software.

Protein Crystallization and Structure Determination—The NmrANADP+ complex was crystallized in form A (trigonal, space group P3221, one molecule per asymmetric unit) using the conditions described previously (4, 5). X-ray data were collected at European Synchrotron Radiation Facility, Grenoble, France, on beamline ID29 using a wavelength of 0.99187 Å. The crystals were flash-frozen using 20% (v/v) glycerol as a cryoprotectant prior to data collection and maintained at 100 K. Data indexing/integration and merging were carried out using DENZO and SCALEPCK, respectively (21). Structure refinement used CNS (22), whereas model building was carried out using O (23) on an SGI Octane2 work station. The native NmrA coordinates (Protein Data Bank code 1K61 [PDB] ) were used for rigid body refinement, followed by simulated annealing and positional and individual B-factor refinement. Data collection and refinement statistics are shown in Table IV. Figures of molecular models were created using VMD (24).


View this table:
[in this window]
[in a new window]
 
TABLE IV
Statistics for crystallographic structure determination

Outer shell data are given in parentheses.

 

Energy Minimization of NmrA Dinucleotide Complexes—Minimization was carried out using the program NAMD2 (25) utilizing the CHARMM22 force field. NADH was initially placed in the same position as NAD+ as observed from the crystal structure with NmrA (5). The system was then subjected to conjugate gradient minimization in the presence of water (coordinates obtained from the crystal structure). The very similar structures of NmrA seen in different crystal forms indicated a relatively rigid conformation for the protein, and hence the NAD(P)H-binding site was fixed except for the following key residues: His-37, Lys-131 Gly-151, Tyr-153, Asn-156, and Tyr-276. As a control, NAD+ was also subjected to the same protocol.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
NmrA Discriminates between Oxidized Dinucleotides and Their Reduced Forms—Purified NmrA was used in microcalorimetry experiments to quantify any interaction with NAD+, NADP+, NADH, and NADPH in HEPES, phosphate, PIPES, TES, and Tris buffers. The results of an ITC analysis (see Tables I, II, III) showed that NmrA was able to bind exothermically with 1:1 stoichiometry and moderate affinity to oxidized dinucleotides with an average KD in the region of 47 and 82 µM for NAD+ and NADP+, respectively. No binding of the reduced forms could be detected.


View this table:
[in this window]
[in a new window]
 
TABLE I
Thermodynamic parameters for the binding of NmrA to AreA662 as determined by ITC at 25 °C

The binding of NmrA to AreA662 was measured in phosphate buffer by ITC at the concentrations indicated. Shown are the values for n, the stoichiometry of binding; KD, the equilibrium dissociation constant; {Delta}Hobs, the observed enthalpy; and {Delta}So, the standard entropy change for single site binding. The c values fall within the range 1-1000 that allows the isotherms to be accurately deconvoluted to derive K values (41).

 

View this table:
[in this window]
[in a new window]
 
TABLE II
Thermodynamic parameters for the binding of NmrA to NAD+ as determined by ITC at 25 °C

The binding of NmrA to NAD+ was measured in the buffers shown by ITC at the concentrations indicated. The ±S.D. error estimates are as determined by the fitting software for individual experiments. Shown are the values for n, the stoichiometry of binding; KD, the equilibrium dissociation constant; {Delta}Hobs, the observed enthalpy; and {Delta}So, the standard entropy change for single site binding. The c values fall within the range 1-1000 that allows the isotherms to be accurately deconvoluted to derive K values (41).

 

View this table:
[in this window]
[in a new window]
 
TABLE III
Thermodynamic parameters for the binding of NmrA to NADP+ as determined by ITC at 25 °C

The binding of NmrA NADP+ was measured in the buffers shown by ITC at the concentrations indicated. The ±S.D. estimates are as determined by the fitting software for individual experiments. Shown are the values for n, the stoichiometry of binding; KD, the equilibrium dissociation constant; {Delta}Hobs, the observed enthalpy; and {Delta}So, the standard entropy change for single site binding. The c values fall within the range 1-1000 that allows the isotherms to be accurately deconvoluted to derive K values (41).

 

The ITC results were confirmed by differential scanning calorimetry (DSC) experiments (using a phosphate buffer) showing the effects of oxidized and reduced dinucleotides on the thermal stability of NmrA in solution under similar conditions (see Fig. 1). In the absence of added ligand, NmrA undergoes an endothermic thermal unfolding transition with Tm {approx} 48.5 (±0.5) °C and mean enthalpy, {Delta}H = 670 (±50) kJ mol1. Although the unfolding transition is irreversible under these conditions, the ratio of calorimetric to van't Hoff enthalpies, {Delta}Hcal/{Delta}HVH = 1.05 (±0.12) is consistent with cooperative unfolding of a monomeric protein unit.



View larger version (15K):
[in this window]
[in a new window]
 
FIG. 1.
DSC data (offset for clarity) comparing the thermal unfolding transitions of NmrA (17 µM) in the presence and absence of 3 mM oxidized or reduced dinucleotides. Heat capacity data are corrected for instrumental (buffer) base line, and concentration was normalized (1 cal = 4.184 J). The dashed line indicates the Tm (48.5 °C) of free protein and highlights the relatively large increase in thermal stability in the presence of NAD+ (52.5 °C) or NADP+ (51.6 °C), compared with the much smaller effects with NADH (49.3 °C) or NADPH (49.4 °C).

 

Addition of 3 mM NAD+ or NADP+ raises the Tm by about 4 °C, whereas the same concentration of reduced dinucleotides has only a marginal effect ({delta}Tm {approx} 0.5–1 °C). For a ligand that binds to the native (folded) state of a protein, the increase in Tm can be related to the dissociation constant (KL) and concentration of ligand, [L], as shown in Equation 1,

(Eq. 1)
in which {delta}Tm = TmTm,0 is the change in unfolding transition temperature; R is the gas constant, and {Delta}Hunf,0 is the unfolding enthalpy of the protein in the absence of ligand (26, 27). By using the data from DSC in the presence and absence of ligand with [L] = 3 mM, this expression gives estimates for KL {approx} 0.15 (±0.08) and 0.37 (±0.07) mM for NAD+ and NADP+, respectively, compared with much weaker values of 4.8 (±2.7) and 7.2 (±1.1) mM for NADH and NADPH under the same conditions. This is consistent with the more direct calorimetric titration data and shows clear discrimination in binding affinities for the oxidized and reduced forms of these ligands. It must be borne in mind that the DSC data relate to ligand binding at higher temperatures in the region of Tm where ligand binding affinities will be weaker compared with those determined by ITC at 25 °C. These ligand binding properties suggest the possibility that the binding of NAD+ may modulate some aspect of the in vivo activity of NmrA. We are currently engaged in experiments to test this possibility.

Binding of NAD+ and NADP+ to NmrA Is Associated with Proton Uptake and Release—The {Delta}Hobs values given in Table IV are the observed enthalpy changes. These values include any heats of ionization that may be associated with the buffers and the reactants. The possibility that the {Delta}Hobs contains a component arising from heats of ionization can be checked by plotting {Delta}Hobs against the ionization enthalpies of the buffers used. Fig. 2 shows {Delta}Hobs plotted against the ionization enthalpies, {Delta}Hi, of the HEPES, PIPES, TES, and Tris buffers. These plots indicate that NAD+ binding is associated with proton release, and NADP+ binding is associated with proton uptake. The {Delta}Hobs values for NAD+ and NADP+ in phosphate buffer do not fit the trend of the plots shown in Fig. 2. The reason for this may be because the Rossmann fold has within it a pyrophosphate-binding site, and it is conceivable that phosphate can bind poorly to this site thereby acting as a weak inhibitor.



View larger version (12K):
[in this window]
[in a new window]
 
FIG. 2.
Linear regression analysis of a plot of {Delta}Hobs versus the heat of ionization, {Delta}Hi, of the buffers PIPES, HEPES, TES, and Tris. Data from two independent experiments are shown. The closed squares for NAD+ binding and the open squares for NADP+ binding are generated from the data shown in Tables I, II, III.

 

Structure of NmrA Complexed with NADP+ and Modeling Studies of NAD(P)+/NAD(P)H Discrimination—As a follow up to the calorimetry work that showed NmrA does not discriminate between NAD+ and NADP+ yet does in respect to oxidized/reduced nicotinamide adenine dinucleotides, we undertook structural studies in order to rationalize such observations at the molecular level. First, the crystal structure of NmrA complexed with NADP+ was determined and refined to 1.7 Å resolution (Protein Data Bank code 1PDS [PDB] ). From the omit map shown in Fig. 3A, the NADP+-binding site is clear and is positioned in a similar overall location to NAD+ (5) yet with a significant difference in conformation for the adenosine fragment of the molecule (Fig. 3C). A number of hydrogen-bonding interactions occur between the protein and the NMN fragment of NADP+ including Tyr-153 nitrogen to the nicotinamide oxygen, Gln-17 main-chain nitrogen to the 1 phosphate, and Arg-16 guanidinium to the 2 phosphate group. Further contacts with the nicotinamide include van der Waals interactions with Met-113 and ring stacking with the side chain of Tyr-153. Many of these interactions are the same as seen for the complex of NAD+ with NmrA. There are, however, clear conformational differences between NAD+ and NADP+ in the adenosine portion of the dinucleotides. In the crystal structure of NAD+ complexed with NmrA, the glycosidic bond of adenine, lies in the anti conformation and is set at 0° allowing the ring to make close stacking interactions with the side chain of His-37. NADP+ adopts a different adenine ring conformation to NAD+ due to the presence of the 2'-phosphate and in the complex with NmrA has the glycosidic bond of adenine residing at 91°; nevertheless, an equivalent ring stacking interaction of the adenine ring with the side chain of His-37 is maintained by flipping the latter by ~180° as shown in Fig. 3C. In addition, there is a movement of the adenosine ribose via a rotation of ~70° about the C-5'–O-5' bond relative to NAD+, shifting it toward residue Gln-84. The different adenine ring position in NADP+ compared with NAD+ leads to the loss of a hydrogen bond to the Thr-82 side-chain hydroxyl. However, the 2'-phosphate of NADP+ makes interactions to the side-chain hydroxyl of Thr-14 via a water molecule.



View larger version (37K):
[in this window]
[in a new window]
 
FIG. 3.
A, omit map for NADP+ in its binding site on NmrA. The map is contoured at 2.7{sigma} and shows clear density for the ligand. B, interaction of NADP+ with NmrA. Stereo diagram with key residues indicated. Hydrogen bond contacts (in purple) are shown between atoms. NmrA is depicted in schematic format. C, comparison of the conformations of NADP+ and NAD+ when bound to NmrA. Stereo diagram with NAD+ shown in green and NADP+ in orange. D, NAMD2 minimization of NADH. Stereo diagram showing the modeling results obtained using NAMD2 with NADH. Protein hydrogen atoms and water molecules have been omitted for clarity. The starting conformation of NADH is indicated in gray, and the minimized structure is shown in red, and the conformation of the protein is shown as in the minimized structure. Key interactions are indicated with dashed lines, and atom labels define the following bond lengths: O-1—H-1, 2.45 Å; O-1—H-1', 3.11 Å; O-2—H-2, 2.66 Å; O-3—H-3, 2.65 Å; O-3–H3', 2.59 Å. Overall, there was very little difference in the conformation of these residues before and after modeling, except in the case of Tyr-276, which moved slightly by 0.73 Å. Hence, no bond has been shown between this and the starting conformation of NADH.

 

Preliminary modeling studies have been used to assess structural features in NmrA that could contribute to the putative redox sensing mechanism, in particular as to why the protein binds NAD(P)H with low affinity compared with NAD(P)+. Energy minimization of NmrA using NAMD2 indicates differences in the final conformation of NADH relative to NAD+ in the NmrA-binding site, such that the nicotinamide ring of NADH has been displaced from its starting position. NAD+ was found to be maintained in the same state as the crystal structure. The reduced nicotinamide has two different puckered conformers, both of which give steric clashes between the additional hydrogen atoms present at the C4-position and the backbone oxygen atom in residue Gly-151 as well as the Tyr-276 side-chain hydroxyl group. The loss of aromaticity of the nicotinamide ring in NAD(P)H is also likely to weaken binding as ring stacking interactions with the side chain of Tyr-153 will be attenuated (28). There is also a distortion of the hydrogen bonding interactions of the amide group in the puckered conformers with the side chain of Asn-156. A further factor is the positive charge in the nicotinamide ring of NAD(P)+ which is delocalized causing the outer hydrogens to have a partial charge (29). The polar nature of these hydrogens may allow weak electrostatic interactions between NAD(P)+ and the backbone oxygen atoms of residues Gly-151 and Ala-150 in NmrA. Similar interactions of this nature are observed with other protein ligand complexes (30). However, in NADH the C-4 hydrogen atoms can no longer partake in such an interaction, which results in a steric clash with the backbone oxygen of Gly-151, when in the planar conformation (Fig. 3D). By using the ligand docking program G.O.L.D (31), the experimentally determined binding position of the nicotinamide mononucleotide portion of NAD+ and NADP+ in NmrA could be accurately reproduced. G.O.L.D. also gave consistently lower fitness scores with NADH compared with NAD+ and docked NADH in a displaced position from NAD+.

In the case of nicotinamide adenine dinucleotide- binding enzymes in general, there is normally high selectivity for NAD+ relative to NADP+ and vice versa. Whereas this discrimination cannot be put down to a particular common set of residues, nevertheless "fingerprint" interactions for NAD+ (a side-chain carboxylate interacting with the adenosine ribose hydroxyls) and for NADP+ (an arginine facing the adenine plane and interacting with the pyrophosphate) have been identified (32, 33). Unusually dihydrodipicolinate reductase shows a relatively low discrimination between NADH and NADPH of 4-fold, and in this case the carboxylate of Glu-38 interacts with the adenosine ribose hydroxyls of NADH but does not make this interaction in the NADPH complex (34). The dihydrodipicolinate reductase NADPH complex has an interaction that is not present in the NADH complex involving Arg-39. In this case the arginine hydrogen bonds to the 2'-phosphate rather than the pyrophosphate group, which is characteristic of the normal fingerprint interaction for NADP+. NADP+-specific SDRs have a pair of conserved basic residues (Lys-17 and Arg-39 in carbonyl reductase) that have been suggested as providing the recognition for this dinucleotide by interacting with the 2'-phosphate (35). Interestingly in NmrA, which does not discriminate between NAD+ and NADP+, there are no homologous residues to these positions in carbonyl reductase. Also, significantly, for NmrA both fingerprint interactions for NAD+ and NADP+ are absent. The observed rearrangement of His-37 allows NmrA to bind either NAD+ or NADP+ by accommodating the differing conformations of the adenine ring moieties of these two dinucleotides.

NmrA Binds to a C-terminal Fragment of AreA—Previous work with NMR1 showed that in vitro it interacted with the C-terminal region of NIT2 (17). In order to characterize the kinetics of any interaction between NmrA and the C-terminal region of AreA, we deleted the N-terminal 662 amino acids of AreA to produce a small C-terminal fragment (designated AreA662) for this analysis (see "Experimental Procedures"). This C-terminal fragment of AreA contains the zinc finger region and was able to bind to the niaD promoter (36) in vitro in electrophoretic mobility shift assay experiments (data not shown).

NmrA and AreA662 were purified in bulk and used in ITC experiments to determine whether they interacted with one another. We carried out experiments in which NmrA in the injector syringe was titrated into AreA662 in the reaction cell. The results of these experiments are shown in Tables I, II, III, where it can be seen that NmrA and AreA662 interacted endothermically with a 1:1 stoichiometry and an average KD of 0.26 µM. Fig. 4 shows typical results of the titration of NmrA into AreA662.



View larger version (21K):
[in this window]
[in a new window]
 
FIG. 4.
Typical ITC data for the endothermic binding of NmrA to AreA at 25 °C. Upper panel, heat uptake upon injection (1 x 2 µl and 24 x 10 µl) of NmrA (454 µM) into the calorimetric cell (1.4 ml) containing AreA662 at 37.5 µM. Heat pulses in the absence of AreA (not shown) were negligible. Lower panel, integrated heat pulses, normalized per mol of injectant, giving a differential binding curve that is adequately described by a single-site binding model.

 

In order to determine whether nucleotide binding was affected by the interaction of AreA with NmrA, we carried out experiments in which NAD+, NADH, or NADP+ in the injector syringe was titrated into an approximately equimolar mixture of NmrA and AreA662. The resulting thermograms were not significantly different from those observed in the absence of AreA, indicating that formation of the NmrA-AreA complex does not inhibit (oxidized) nucleotide binding nor does it affect the discrimination between oxidized and reduced forms. This is consistent with the structural studies that show that the nucleotide-binding site in NmrA is distant from the putative AreA interaction region.

NmrA Is Unable to Bind the Nitrogen Metabolite Repression Signal Molecules Ammonium or Glutamine—The fact that NmrA can bind NAD+, NADP+, and AreA662 implies that the protein is in a native state able to bind physiological ligands after our purification protocol. We used ITC to probe the ability of NmrA to bind the nitrogen metabolite repression signal molecule glutamine in a binary complex and in a ternary complex with AreA662. We were unable to detect any significant heat of binding when glutamine was added to a solution of AreA662 (40 µM) or NmrA. Also when the ITC cell contained NmrA (44.6 µM) previously titrated with AreA662 (312 µM), no heat of binding was observed when glutamine was titrated into the NmrA-AreA complex. We also used circular dichroism and fluorescence emission spectroscopy as independent techniques to probe the ability of NmrA to bind ammonium or glutamine in a binary complex; however, no conformational changes and no binding could be detected (data not shown).


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
We have quantified for the first time the ligand binding properties of NmrA, a protein that plays a major role in the signal transduction pathway controlling nitrogen metabolite repression in microbial eukaryotes. Calorimetry reveals that NmrA does not discriminate between NAD+ and NADP+ but can effectively discriminate between the oxidized and reduced forms. Structure determination of the complex of NmrA with NADP+ and comparison with the previous NAD+ complex reveal that repositioning of His-37 allows the significantly different conformations of the adenosine moiety of the two dinucleotides to be accommodated within the same binding site. Additionally, it may be noted that some structural features that have been ascribed to the NAD+/NADP+ discrimination in SDRs have been lost in NmrA (35). Because a range of mutations are needed to change NAD+/NADP+ selectivity (32), it would seem that the ancestral ability of the SDR fold in NmrA to discriminate between NAD+ and NADP+ is unlikely to have been lost as the result of a single mutation that has become fixed through a stochastic event. The unusual ability of NmrA to bind NAD+ and NADP+ with equal affinity is more likely to be the result of evolutionary selection and implies that it may be of physiological importance. Similarly the ability of NmrA to discriminate between NAD(P)+ and NADPH may have a biological function. The molecular basis for this discrimination between oxidized and reduced dinucleotides has been investigated by studies that show the reduced nicotinamide ring produces steric clashes and loss of aromatic ring stacking and electrostatic interactions with NmrA. Calorimetry also demonstrates that NmrA is able to bind to AreA662, a C-terminal fragment of AreA, a protein that plays an essential role in the positive control of transcription, with a 1:1 stoichiometry and an apparent KD of 0.26 µM.

The signal transduction pathway involving NmrA has been implicated in monitoring the intracellular levels of the nitrogen metabolite repression signal molecule glutamine (37). However, CD spectroscopy, fluorescence, and calorimetry provide no evidence that NmrA can recognize ammonium or glutamine in either a binary complex or a ternary complex with AreA662. The inability of NmrA to bind ammonium or glutamine in a binary complex or a ternary complex with AreA662 may mean that NmrA is not involved in the glutamine sensing signal transduction pathway that controls wild-type nitrogen metabolite repression. Glutamine-binding sites may exist on other regions of AreA or only in a higher order complex when additional components are present.

We note that two radically different models for the ability of NmrA to modulate the activity of AreA can be envisaged. NmrA may interact directly with AreA while it is complexed with DNA and disrupt its interaction with pathway-specific transcription-regulating proteins or the accessory transcription apparatus. On the other hand, NmrA may exert its affect by controlling the access of AreA to its target promoters by either a direct or indirect route. The direct route could involve occlusion of the zinc finger region (17), or it could act indirectly by controlling the rate of entry of AreA into the nucleus. The moderate affinity for the oxidized dinucleotides (average value 65 µM) means that in order to have a substantial proportion of the population in a binary complex with NAD+/NADP+, NmrA must be in an environment with oxidized nucleotides in the high micromolar range. The free intracellular and nuclear concentrations of oxidized and reduced nucleotides in A. nidulans are not known, and their determination is beyond the scope of this current study. However, overall intracellular concentrations of 1 mM for NAD+ plus NADH have been reported in the microbial eukaryote Saccharomyces cerevisiae (38), and there is no reason to assume that A. nidulans will differ dramatically. If this situation is reflected in A. nidulans, then a dinucleotide signal recognition role for NmrA may be restricted to the cytosol where NmrA is most likely to encounter the highest concentrations of NAD+/NADP+. If NmrA functions to control the access of AreA to the nucleus, the binding of oxidized dinucleotides could modulate this ability.

The ligand binding properties of NmrA show some interesting parallels to those of the CtBP class of transcriptional corepressor. The latter proteins are related to a metabolic enzyme, in the case of CtBP, sharing a high degree of amino acid sequence homology with NAD+-dependent 2-hydroxy acid dehydrogenases. Whereas NmrA shares no sequence identity with dehydrogenases, it nevertheless has a three-dimensional structure related to the SDR superfamily. CtBP proteins are widespread and are conserved between vertebrates and invertebrates being involved in transcriptional pathways important for development, cell cycle regulation, and transformation (39, 40). CtBP binding to cellular and viral transcriptional repressors is regulated by NAD+ and NADH, with NADH being 2–3 orders of magnitude more effective. It is proposed that the ability of CtBP to detect changes in nuclear NAD+/NADH ratio allows it to serve as a redox sensor for transcription (39). In the case of NmrA, however, NAD+ binds more effectively than NADH, and it interacts with a wide domain GATA-type transcription activator rather than a transcription repressor. Further studies of the AreA/NmrA transcriptional regulatory system including investigations into the role of NAD+ will allow more detailed understanding of potential relationships with other transcription factors that are thought to have roles in redox sensing.


    FOOTNOTES
 
The atomic coordinates and structure factors (code 1PDS [PDB] ) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

* This work was supported by the Biotechnology and Biological Sciences Research Council and the Wellcome Trust. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

§ Both authors contributed equally to this work. Back

** To whom correspondence may be addressed. Tel.: 44-1865-287-565; Fax: 44-1865-287-547; E-mail: daves{at}strubi.ox.ac.uk.

{ddagger}{ddagger} To whom correspondence may be addressed. Tel.: 44-191-2227673; Fax: 44-191-2227424; E-mail: a.r.hawkins{at}ncl.ac.uk.

1 The abbreviations used are: DTT, dithiothreitol; DSC, differential scanning calorimetry; ITC, isothermal titration calorimetry; SDR, short-chain dehydrogenase reductase; PIPES, 1,4-piperazinediethanesulfonic acid; TES, 2-{[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino}ethanesulfonic acid. Back


    ACKNOWLEDGMENTS
 
The Biological Microcalorimetry facility in Glasgow is funded jointly by the Biotechnology and Biological Sciences Research Council and Engineering and Physical Sciences Research Council. We thank Elaine Cairns for technical assistance.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Wilson, R. A., and Arst, H. N., Jr. (1998) Microbiol. Mol. Biol. Rev. 62, 586–596[Abstract/Free Full Text]
  2. Dunn-Coleman, N. S., Tomsett, A. B., and Garrett, R. H. (1979) J. Bacteriol. 139, 697–700[Abstract/Free Full Text]
  3. Andrianopoulos, A., Kourambas, S., Sharp, J. A., Davis, M. A., and Hynes, M. J. (1998) J. Bacteriol. 180, 1973–1977[Abstract/Free Full Text]
  4. Nichols, C. E., Cocklin, S., Dodds, A., Ren, J., Lamb, H., Hawkins, A. R., and Stammers, D. K. (2001) Acta Crystallogr. Sect. D Biol. Crystallogr. 57, 1722–1725[CrossRef][Medline] [Order article via Infotrieve]
  5. Stammers, D. K., Ren, J., Leslie, K., Nichols, C. E., Lamb, H. K., Cocklin, S., Dodds, A., and Hawkins, A. R. (2001) EMBO J. 20, 6619–6626[CrossRef][Medline] [Order article via Infotrieve]
  6. Thoden, J. B., Wohlers, T. M., Fridovich-Keil, J. L., and Holden, H. M. (2000) Biochemistry 39, 5691–5701[CrossRef][Medline] [Order article via Infotrieve]
  7. Jornvall, H., Persson, B., Krook, M., Atrian, S., Gonzalez-Duarte, R., Jeffery, J., and Ghosh, D. (1995) Biochemistry 34, 6003–6013[CrossRef][Medline] [Order article via Infotrieve]
  8. Rutter, J., Reick, M., Wu, L. C., and McKnight, S. L. (2001) Science 293, 510–514[Abstract/Free Full Text]
  9. Grove, G., and Marzluf, G. A. (1981) J. Biol. Chem. 256, 463–470[Abstract/Free Full Text]
  10. Davis, M. A., and Hynes, M. J. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 3753–3757[Abstract/Free Full Text]
  11. Fu, Y. H., and Marzluf, G. A. (1990) Mol. Cell. Biol. 10, 1056–1065[Abstract/Free Full Text]
  12. Marzluf, G. A. (1997) Microbiol. Mol. Biol. Rev. 61, 17–32[Abstract]
  13. Platt, A., Langdon, T., Arst, H. N., Jr., Kirk, D., Tollervey, D., Sanchez, J. M., and Caddick, M. X. (1996) EMBO J. 15, 2791–2801[Medline] [Order article via Infotrieve]
  14. Muro-Pastor, M. I., Gonzalez, R., Strauss, J., Narendja, F., and Scazzocchio, C. (1999) EMBO J. 18, 1584–1597[CrossRef][Medline] [Order article via Infotrieve]
  15. DeBusk, R. M., and Ogilvie, S. (1984) J. Bacteriol. 160, 493–498[Abstract/Free Full Text]
  16. Young, J. L., and Marzluf, G. A. (1991) Biochem. Genet. 29, 447–459[Medline] [Order article via Infotrieve]
  17. Xiao, X., Fu, Y. H., and Marzluf, G. A. (1995) Biochemistry 34, 8861–8868[CrossRef][Medline] [Order article via Infotrieve]
  18. Maniatis, T., Fritsch, E. F., and Sambrook, J. (1982) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, New York
  19. Lamb, H. K., Newton, G. H., Levett, L. J., Cairns, E., Roberts, C. F., and Hawkins, A. R. (1996) Microbiology 142, 1477–1490[Abstract/Free Full Text]
  20. Lamb, H. K., Moore, J. D., Lakey, J. H., Levett, L. J., Wheeler, K. A., Lago, H., Coggins, J. R., and Hawkins, A. R. (1996) Biochem. J. 313, 941–950[Medline] [Order article via Infotrieve]
  21. Otwinowski, Z., and Minor, W. (1996) Methods Enzymol. 276, 307–326
  22. Brunger, A. T., Adams, P. D., Clore, G. M., Delano, W. L., Gros, P., Grosse, K. R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Acta Crystallogr. 54, 905–921
  23. Jones, T. A., Zou, J. Y., Cowan, S. W., and Kjeldgaard, M. (1991) Acta Crystallogr. 47, 110–119[Medline] [Order article via Infotrieve]
  24. Humphrey, W., Dalke, A., and Schulten, K. (1996) J. Mol. Graph. 14, 33–38[CrossRef][Medline] [Order article via Infotrieve]
  25. Kale, L., Skeel, R., Bhandarkar, M., Brunner, R., Gursoy, A., Krawetz, N., Phillips, J., Shinozaki, A., Varadarajan, K., and Schulten, K. (1999) J. Comput. Phys. 151, 283–312[CrossRef]
  26. Cooper, A., Nutley, M. A., and Wadood, A. (2000) in Protein-Ligand Interactions: Hydrodynamics and Calorimetry (Harding, S. E. and Chowdry, B. Z., eds) pp. 287–318, Oxford University Press, Oxford, UK
  27. Cooper, A. (1999) in Protein: A Comprehensive Treatise (Allen, G., ed) Vol. 2, pp. 217–270, JAI Press Inc., Greenwich, CT
  28. McGaughey, G. B., Gagne, M., and Rappe, A. K. (1998) J. Biol. Chem. 273, 15458–15463[Abstract/Free Full Text]
  29. Levitt, M., and Perutz, M. F. (1988) J. Mol. Biol. 201, 751–754[CrossRef][Medline] [Order article via Infotrieve]
  30. Klaholz, B., and Moras, D. (2002) Structure 10, 1197–1204[Medline] [Order article via Infotrieve]
  31. Jones, G., Willett, P., Glen, R. C., Leach, A. R., and Taylor, R. (1997) J. Mol. Biol. 267, 727–748[CrossRef][Medline] [Order article via Infotrieve]
  32. Carugo, O., and Argos, P. (1997) Proteins 28, 29–40[CrossRef][Medline] [Order article via Infotrieve]
  33. Carugo, O., and Argos, P. (1997) Proteins 28, 10–28[CrossRef][Medline] [Order article via Infotrieve]
  34. Reddy, S. G., Scapin, G., and Blanchard, J. S. (1996) Biochemistry 35, 13294–13302[CrossRef][Medline] [Order article via Infotrieve]
  35. Tanaka, N., Nonaka, T., Nakanishi, M., Deyashiki, Y., Hara, A., and Mitsui, Y. (1996) Structure 4, 33–45[Medline] [Order article via Infotrieve]
  36. Punt, P. J., Strauss, J., Smit, R., Kinghorn, J. R., van den Hondel, C. A., and Scazzocchio, C. (1995) Mol. Cell. Biol. 15, 5688–5699[Abstract]
  37. Morozov, I. Y., Galbis-Martinez, M., Jones, M. G., and Caddick, M. X. (2001) Mol. Microbiol. 42, 269–277[CrossRef][Medline] [Order article via Infotrieve]
  38. Bakker, B. M., Overkamp, K. M., van Maris, A. J., Kotter, P., Luttik, M. A., van Dijken, J. P., and Pronk, J. T. (2001) FEMS Microbiol. Rev. 25, 15–37[CrossRef][Medline] [Order article via Infotrieve]
  39. Chinnadurai, G. (2002) Mol. Cell 9, 213–224[CrossRef][Medline] [Order article via Infotrieve]
  40. Schaeper, U., Boyd, J. M., Verma, S., Uhlmann, E., Subramanian, T., and Chinnadurai, G. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 10467–10471[Abstract/Free Full Text]
  41. Wiseman, T., Williston, S., Brandts, J. F., and Lin, L. N. (1989) Anal. Biochem. 179, 131–137[CrossRef][Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
K. G. Zulak, M. F. Khan, J. Alcantara, D. C. Schriemer, and P. J. Facchini
Plant Defense Responses in Opium Poppy Cell Cultures Revealed by Liquid Chromatography-Tandem Mass Spectrometry Proteomics
Mol. Cell. Proteomics, January 1, 2009; 8(1): 86 - 98.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
M. R. Sadykov, M. E. Olson, S. Halouska, Y. Zhu, P. D. Fey, R. Powers, and G. A. Somerville
Tricarboxylic Acid Cycle-Dependent Regulation of Staphylococcus epidermidis Polysaccharide Intercellular Adhesin Synthesis
J. Bacteriol., December 1, 2008; 190(23): 7621 - 7632.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
B. Schonig, D. W. Brown, B. Oeser, and B. Tudzynski
Cross-Species Hybridization with Fusarium verticillioides Microarrays Reveals New Insights into Fusarium fujikuroi Nitrogen Regulation and the Role of AreA and NMR
Eukaryot. Cell, October 1, 2008; 7(10): 1831 - 1846.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
H. K. Lamb, D. K. Stammers, and A. R. Hawkins
Dinucleotide-Sensing Proteins: Linking Signaling Networks and Regulating Transcription
Sci. Signal., August 19, 2008; 1(33): pe38 - pe38.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
K. H. Wong, M. J. Hynes, and M. A. Davis
Recent Advances in Nitrogen Regulation: a Comparison between Saccharomyces cerevisiae and Filamentous Fungi
Eukaryot. Cell, June 1, 2008; 7(6): 917 - 925.
[Full Text] [PDF]


Home page
Eukaryot CellHome page
R. B. Todd, J. A. Fraser, K. H. Wong, M. A. Davis, and M. J. Hynes
Nuclear Accumulation of the GATA Factor AreA in Response to Complete Nitrogen Starvation by Regulation of Nuclear Export
Eukaryot. Cell, October 1, 2005; 4(10): 1646 - 1653.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
C. Vuong, J. B. Kidder, E. R. Jacobson, M. Otto, R. A. Proctor, and G. A. Somerville
Staphylococcus epidermidis Polysaccharide Intercellular Adhesin Production Significantly Increases during Tricarboxylic Acid Cycle Stress
J. Bacteriol., May 1, 2005; 187(9): 2967 - 2973.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
G. W. Templeton and G. B.G. Moorhead
A Renaissance of Metabolite Sensing and Signaling: From Modular Domains to Riboswitches
PLANT CELL, September 1, 2004; 16(9): 2252 - 2257.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/34/32107    most recent
M304104200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lamb, H. K.
Right arrow Articles by Hawkins, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lamb, H. K.
Right arrow Articles by Hawkins, A. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement